Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Round
EVANSTON, Ill., Dec. 24, 2021 -- (Healthcare Sales & Marketing Network) -- Rhaeos, Inc., a private, clinical stage medical device company developing a platform wireless and non-invasive wearable sensor initially targeting the neurosurgical suite, today an... Devices, Monitoring, Neurosurgery, Venture Capital Rhaeos , FlowSense, hydrocephalus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Hydrocephalus | Marketing | Medical Devices | Neurology | Neurosurgery | Pharmaceuticals | Venture Capital